In its most recent SEC filing covering the third quarter, Meritage Portfolio Management disclosed an 8.7% reduction in its position in JPMorgan Chase & Co., selling 5,129 shares to end the period with 53,824 shares outstanding. The stake, valued at approximately $17.0 million at quarter end, represents 1.1% of Meritage’s total assets and ranks as its 12th largest holding. This reallocation follows a trend of selective profit-taking by mid-sized asset managers in large-cap financials.

JPMorgan Chase & Co. reported quarterly revenue of $46.77 billion, up 7.1% year-over-year, and delivered $5.23 in earnings per share, beating consensus by $0.30. Return on equity reached 17.16% and net margin stood at 20.35%. The board declared a $1.50 per share dividend (annualized $6.00, payout ratio 29.99%), payable January 31 to holders of record January 6. Analysts now project full-year EPS of 18.1, reinforcing the bank’s capacity to sustain capital returns and invest in digital banking initiatives.

During the quarter, General Counsel Stacey Friedman sold 3,404 shares for proceeds totaling $1.06 million, while COO Jennifer Piepszak disposed of 8,571 shares for $2.68 million. Following these transactions, Friedman and Piepszak hold 65,353 and 71,027 shares respectively, marking ownership decreases of 4.95% and 10.77%. Total insider dispositions reached 15,834 shares valued at $4.95 million, consistent with JPMorgan’s policy permitting limited share sales to diversify personal portfolios.

Fourteen analysts maintain Buy ratings on JPMorgan, thirteen recommend Hold and one issues a Sell, yielding a consensus rating of Hold. Recent target adjustments include Piper Sandler lifting its objective to $345 and Morgan Stanley setting a $331 target, reflecting confidence in the bank’s diversified revenue streams. Conversely, Zacks Research downgraded to Hold on valuation concerns. The average consensus target stands at $336.32, implying mid-single-digit upside from current levels.